MiR-4788 promotes NSCLC progression by targeting DLG5 to enhance mitochondrial function

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Non-small cell lung cancer (NSCLC) is a major global health concern with high mortality rates.
• MicroRNAs (miRNAs) are implicated in cancer progression, but the specific role of miR-4788 in NSCLC is unknown.
• This study aimed to elucidate the function and mechanism of miR-4788 in NSCLC.

Purpose of the Study:

• To investigate the role of miR-4788 in NSCLC proliferation and metastasis.
• To identify the molecular mechanism underlying miR-4788's function in NSCLC.
• To explore the prognostic significance of miR-4788 in NSCLC patients.

Main Methods:

• Analysis of miR-4788 expression and survival data from The Cancer Genome Atlas (TCGA).
• In vitro studies using NSCLC cell lines with miR-4788 mimics or DLG5 manipulation.
• In vivo validation in zebrafish and murine xenograft models, including functional assays for proliferation, migration, invasion, and mitochondrial function.

Main Results:

• miR-4788 is upregulated in NSCLC and correlates with poorer survival.
• Overexpression of miR-4788 enhances NSCLC cell proliferation, migration, and invasion.
• miR-4788 promotes mitochondrial function and inhibits mitophagy by directly targeting DLG5.

Conclusions:

• miR-4788 acts as an oncogene in NSCLC, driving tumor progression via the miR-4788-DLG5 axis.
• Targeting DLG5 and modulating mitochondrial metabolism are key mechanisms.
• The miR-4788-DLG5 pathway offers potential therapeutic strategies for NSCLC, possibly impacting tumor metabolism and immune microenvironment.